Evidence map›Paper›PMID 35200640›Full record

ArticleMarine drugs2022

Algal-Derived Halogenated Sesquiterpenes from

Guilherme Senna Dos Santos, Patrícia Aoki Miyasato, Erika Mattos Stein, Pio Colepicolo, Anthony D Wright, Carlos Alberto de Bragança Pereira, Miriam Falkenberg, Eliana Nakano

Open access · goldAbstract readComparative Study
In one paragraph

Article in Marine drugs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Marine drugs · 2026
    Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Guilherme Senna Dos SantosLaboratory of Parasitology, Butantan Institute, São Paulo 05503-000, SP CEP, Brazil.
Patrícia Aoki MiyasatoLaboratory of Parasitology, Butantan Institute, São Paulo 05503-000, SP CEP, Brazil.
Erika Mattos SteinBiochemistry Department, Chemistry Institute, USP-Universidade de São Paulo, São Paulo 05508-00, SP, Brazil.ORCID 0000-0002-3309-1944
Pio ColepicoloBiochemistry Department, Chemistry Institute, USP-Universidade de São Paulo, São Paulo 05508-00, SP, Brazil.ORCID 0000-0002-2334-1532
Anthony D WrightDKI College of Pharmacy, University of Hawaii at Hilo, Hilo, HI 96720, USA.
Carlos Alberto de Bragança PereiraInstitute of Mathematics and Statistics, USP-Universidade de São Paulo, São Paulo 05503-000, SP CEP, Brazil.ORCID 0000-0001-6315-7484
Miriam FalkenbergDepartment of Pharmaceutical Sciences, Federal University of Santa Catarina, Florianópolis 88040-970, SC, Brazil.
Eliana NakanoLaboratory of Parasitology, Butantan Institute, São Paulo 05503-000, SP CEP, Brazil.ORCID 0000-0002-7839-9600
Instituto Butantan · BRUniversidade de São Paulo · BRUniversidade Federal de Santa Catarina · BRUniversity of Hawaii at Hilo · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schistosomiasis has been controlled for more than 40 years with a single drug, praziquantel, and only one molluscicide, niclosamide, raising concern of the possibility of the emergence of resistant strains. However, the molecular targets for both agents are thus far unknown. Consequently, the search for lead compounds from natural sources has been encouraged due to their diverse structure and function. Our search for natural compounds with potential use in schistosomiasis control led to the identification of an algal species,

Indexed as

AnthelminticsLaurenciaMolluscacidesSesquiterpenesAnimalsLarvaSchistosoma mansoniSchistosomiasisSpiro CompoundsAnthelminticselatolMolluscacidesobtusolrogiololSesquiterpenesSpiro CompoundsBiomphalaria(−)-elatollarvicidemarine natural productsmolluscicideobtusolrogiololSchistosoma mansoniterpenes

Identifiers

PMID35200640
PMCPMC8874501
OpenAlexW4210807119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.